Individuals who microdose psychedelics are approaching this practice methodically and report beneficial effects on their mental health, as well as social, physical and cognitive improvements – according to a study published in BMCPsychiatry.
In the process of IPA, the researcher was drawing upon the participants’ lived experience, trying to make sense of this, whilst also aware that this was being viewed through the researcher’s own lens . This involved taking descriptions of participants experiences, considering the meaning that participants were attributing to these, and identifying the commonalities and differences between participants i.e., interpreting the descriptions provided by participants.
“got to a point where I thought that if I had lost cognition, there was no point in living any more.” “I had taken a macro dose with an underground guide…And I thought it was very positive and was then much more interested in psychedelics.” “I approached it with knowledge rather than just for sake of it…I guess reading into psychedelics based on what was available back then and reading people’s use and reports…Really helped me to be better pilot…”.There was a sense that for Callum his experience of microdosing was about being skilful and technical like a pilot, which enabled him to navigate and be in the driver’s seat of his experience of microdosing.
Feeling the microdose was also apparent as all participants described a sensitivity to the immediate effects of the microdose. Participants explained that once they had microdosed there was an immediate effect that would last that day but would diminish over the non-microdosing days. Jonah summed this up stating
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort - BMC Pulmonary MedicineBackground The pathophysiology, evolution, and associated outcomes of post-COVID dyspnea remain unknown. The aim of this study was to determine the prevalence, severity, and predictors of dyspnea 12 months following hospitalization for COVID-19, and to describe the respiratory, cardiac, and patient-reported outcomes in patients with post-COVID dyspnea. Methods We enrolled a prospective cohort of all adult patients admitted to 2 academic hospitals in Vancouver, Canada with PCR-confirmed SARS-CoV-2 during the first wave of COVID between March and June 2020. Dyspnea was measured 3, 6, and 12 months after initial symptom onset using the University of California San Diego Shortness of Breath Questionnaire. Results A total of 76 patients were included. Clinically meaningful dyspnea (baseline score | 10 points) was present in 49% of patients at 3 months and 46% at 12 months following COVID-19. Between 3 and 12 months post-COVID-19, 24% patients had a clinically meaningful worsening in their dyspnea, 49% had no meaningful change, and 28% had a clinically meaningful improvement in their dyspnea. There was worse sleep, mood, quality of life, and frailty in patients with clinically meaningful dyspnea at 12 months post-COVID infection compared to patients without dyspnea. There was no difference in PFT findings, troponin, or BNP comparing patients with and without clinically meaningful dyspnea at 12 months. Severity of dyspnea and depressive symptoms at 3 months predicted severity of dyspnea at 12 months. Conclusions Post-COVID dyspnea is common, persistent, and negatively impacts quality of life. Mood abnormalities may play a causative role in post-COVID dyspnea in addition to potential cardiorespiratory abnormalities. Dyspnea and depression at initial follow-up predict longer-term post-COVID dyspnea, emphasizing that standardized dyspnea and mood assessment following COVID-19 may identify patients at high risk of post-COVID dyspnea and facilitating early and effective managem
Read more »
BMC Electric Ride Guide: Belvoir Castle and the Leicestershire WoldsThis article includes paid promotion on behalf of BMC Read more about sponsored content Switzerland's BMC are known for making high quality bikes that like being ridden fast, whether it be in the world of road racing or mountain biking. Their 257 AMP AL TWO, though billed as an urban commuting style e-bike, follows very much in that tradition of sleek, precisely-designed bikes built for speed. I thought it would be ideal for a long day ride - on leisure rather than commuting duty - over the rolling beauty of the Leicestershire Wolds.
Read more »
Airedale Hospital chief executive appeals to government over 200 leaks a yearThe boss of Airedale Hospital in Keighley says it experiences more than 200 leaks a year.
Read more »
Why are autistic women more likely to be victims of sexual abuse and violence?Why are autistic women more likely to be victims of sexual abuse and violence? ✍️ layla_mood
Read more »
Depression, cardiometabolic disease, and their co-occurrence after childhood maltreatment: an individual participant data meta-analysis including over 200,000 participants - BMC MedicineBackground Childhood maltreatment is associated with depression and cardiometabolic disease in adulthood. However, the relationships with these two diseases have so far only been evaluated in different samples and with different methodology. Thus, it remains unknown how the effect sizes magnitudes for depression and cardiometabolic disease compare with each other and whether childhood maltreatment is especially associated with the co-occurrence (“comorbidity”) of depression and cardiometabolic disease. This pooled analysis examined the association of childhood maltreatment with depression, cardiometabolic disease, and their comorbidity in adulthood. Methods We carried out an individual participant data meta-analysis on 13 international observational studies (N = 217,929). Childhood maltreatment comprised self-reports of physical, emotional, and/or sexual abuse before 18 years. Presence of depression was established with clinical interviews or validated symptom scales and presence of cardiometabolic disease with self-reported diagnoses. In included studies, binomial and multinomial logistic regressions estimated sociodemographic-adjusted associations of childhood maltreatment with depression, cardiometabolic disease, and their comorbidity. We then additionally adjusted these associations for lifestyle factors (smoking status, alcohol consumption, and physical activity). Finally, random-effects models were used to pool these estimates across studies and examined differences in associations across sex and maltreatment types. Results Childhood maltreatment was associated with progressively higher odds of cardiometabolic disease without depression (OR [95% CI] = 1.27 [1.18; 1.37]), depression without cardiometabolic disease (OR [95% CI] = 2.68 [2.39; 3.00]), and comorbidity between both conditions (OR [95% CI] = 3.04 [2.51; 3.68]) in adulthood. Post hoc analyses showed that the association with comorbidity was stronger than with either disease alone, and the association
Read more »
Gisele Bundchen shares 13-year-old son Benjamin's struggle with bullyingGisele Bundchen recently opened up about herson Benjamin's experiences with bullying for not wanting to follow in the footsteps of dad Tom Brady.
Read more »